Business Context and Reporting Period
This Form 8-K reports on the 2018 annual meeting of stockholders for Mustang Bio, Inc., held on June 14, 2018. The company is incorporated in Delaware and is classified as an emerging growth company.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder votes. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes and Shareholder Votes
Four key matters were submitted to a vote of security holders, all of which were approved:
- Election of Directors: Six nominees were elected with support ranging from 92.89% to 94.24% of votes cast.
- Auditor Ratification: Stockholders ratified the appointment of BDO USA, LLP as the independent registered public accounting firm for the 2018 fiscal year.
- Equity Incentive Plan Amendment: Approved an amendment to the 2016 Incentive Plan to increase the number of authorized shares issuable by 3,000,000 shares.
- Dividend Date Amendment: Approved an amendment to the Certificate of Incorporation to change the annual stock dividend due date from March 13 to January 1.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly a disclosure of voting results.
Key Facts for Investor Verification
- Verify the impact of the 3,000,000 share increase on the 2016 Incentive Plan regarding potential future dilution.
- Confirm the new January 1 dividend due date for future cash flow planning.
- Note the high level of shareholder support for the board of directors (over 92% for all nominees).
- Review the company's most recent 10-K or 10-Q for actual financial performance data, as this 8-K contains none.